Seattle, Nov. 21, 2018 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the resveratrol market was valued US$ 69.1 Million in 2017, and is projected to exhibit a CAGR of 9.7% during the forecast period (2018–2026).
To know the latest trends and insights prevalent in this market, click the link below:
https://www.coherentmarketinsights.com/market-insight/resveratrol-market-2267
Key Trends and Analysis of the Resveratrol Market:
Launches of new resveratrol products are expected to fuel the market growth. For instance, in 2017, Evolva Holding SA launched Veri-te, a branded resveratrol product, indicated to use in various consumer health applications (food supplements and cosmetics). Approval of new resveratrol products in key regions is also expected to drive the market growth during the forecast period. For instance, in 2016, DSM Nutritional Products received European Union (EU) Novel Foods approval for its new resVida, a high purity trans-resveratrol, used for food supplements in capsule or tablet form, at doses of up to 150 mg per day. Furthermore, positive regulatory decisions by major regulatory bodies for resveratrol products are expected to drive growth of the market during the forecast period. For instance, in 2013, Japanese Ministry of Health, Labor and Welfare following request of Evolva Holding SA, classified resveratrol into the non-drug material group. This decision significantly facilitated the approval process of resveratrol products in Japan and is also expected to increase access and adoption of the products in region.
Request Sample Copy of this Report
Key Market Takeaways:
- Resveratrol market is projected to witness CAGR of 9.7% during the forecast period (2018–2026), owing to frequent product launches and approvals of resveratrol products in key regions such as North America, Europe and Asia Pacific
- Application of resveratrol in cosmetic application has significantly supported the market growth, owing to increasing awareness of skincare and beauty health among population
- Increasing ageing population, and high prevalence of cardiovascular diseases, diabetes, and neurological disease are expected to propel demand for resveratrol for treatment and management of such chronic diseases.
- Strategic acquisitions and business expansions by key players are also expected to drive growth of the global resveratrol market
- Major players operating in the resveratrol market include SkinCeuticals, Evolva SA, DSM Nutritionals, Jeunesse Global, VitaMonk, Helix Healthstore, Terraternal, Andorra Life, ResVitale, LLC, Endurance Products Company, RevGenetics, SiChuan Xieli Pharmaceutical Co., Ltd., and others.